NCT00284089
- Conditions
- Subfoveal Choroidal Neovascularization(CNV) Secondary to Age-related Macular Degeneration (AMD)
- Locations
-
- Novartis Tokyo, Japan
Clinical trial condition
Subfoveal Choroidal Neovascularization(CNV) Secondary to Age-related Macular Degeneration (AMD)
Explore clinical trials studying Subfoveal Choroidal Neovascularization(CNV) Secondary to Age-related Macular Degeneration (AMD). Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies